ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 1 filers reported holding ACASTI PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $115 | -8.0% | 250 | 0.0% | 0.00% | – |
Q4 2022 | $125 | -87.5% | 250 | -87.5% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 2,000 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -80.0% | 2,000 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | 0.0% | 2,000 | -60.0% | 0.00% | – |
Q1 2018 | $5,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 684,600 | $527,000 | 0.31% |
Perceptive Advisors | 206,677 | $117,000 | 0.00% |
Virtu Financial LLC | 41,066 | $23,000 | 0.00% |
INTACT INVESTMENT MANAGEMENT INC. | 48,990 | $37,000 | 0.00% |
TORONTO DOMINION BANK | 100 | $0 | 0.00% |
MORGAN STANLEY | 40,000 | $23,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 154,439 | $88,000 | 0.00% |
Citadel Advisors | 32,648 | $19,000 | 0.00% |
BREWIN DOLPHIN LTD | 30 | $17 | 0.00% |
Renaissance Technologies | 18,600 | $11,000 | 0.00% |